Business Description
Il Yang Pharmaceutical Co Ltd
SIC : 2836
ISIN : KR7007570005
Share Class Description:
XKRX:007570: Ordinary SharesCompare
Compare
Traded in other countries / regions
007570.Korea IPO Date
1974-08-28Description
Il Yang Pharmaceutical Co Ltd operates in the Korean healthcare sector. The company is mainly a pharmaceutical product manufacturer. Its business is comprised of four product divisions, which are Medicines, Food, Cosmetics, and Antacid raw materials. Its medicines include anticancer and antibiotics and drugs for the liver, digestive system, and anti-inflammatory drugs. Its Foods division is engaged in the manufacture and sale of food supplements and health drinks.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.22 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.53 | |||||
| Debt-to-EBITDA | 7.01 | |||||
| Interest Coverage | 6.05 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.27 | |||||
| Beneish M-Score | -2.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.6 | |||||
| 3-Year EBITDA Growth Rate | -22.7 | |||||
| 3-Year FCF Growth Rate | -39.2 | |||||
| 3-Year Book Growth Rate | 3.5 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.54 | |||||
| 9-Day RSI | 26.62 | |||||
| 14-Day RSI | 26.27 | |||||
| 6-1 Month Momentum % | -3.19 | |||||
| 12-1 Month Momentum % | -14.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.89 | |||||
| Quick Ratio | 0.55 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 155.99 | |||||
| Days Sales Outstanding | 69.08 | |||||
| Days Payable | 79.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.35 | |||||
| 3-Year Dividend Growth Rate | 7.7 | |||||
| Forward Dividend Yield % | 1.35 | |||||
| 5-Year Yield-on-Cost % | 1.35 | |||||
| 3-Year Average Share Buyback Ratio | 0.4 | |||||
| Shareholder Yield % | -2.55 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.85 | |||||
| Operating Margin % | 5.64 | |||||
| Net Margin % | -0.22 | |||||
| FCF Margin % | -8.33 | |||||
| ROE % | -0.35 | |||||
| ROA % | -0.17 | |||||
| ROIC % | 5.1 | |||||
| ROC (Joel Greenblatt) % | 2.13 | |||||
| ROCE % | 1.81 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.55 | |||||
| PB Ratio | 0.86 | |||||
| Price-to-Tangible-Book | 1.3 | |||||
| Price-to-Operating-Cash-Flow | 114.25 | |||||
| EV-to-EBIT | 55.95 | |||||
| EV-to-EBITDA | 16.98 | |||||
| EV-to-Revenue | 0.81 | |||||
| EV-to-FCF | -9.75 | |||||
| Price-to-Projected-FCF | 0.62 | |||||
| Price-to-Median-PS-Value | 0.29 | |||||
| Earnings Yield (Greenblatt) % | 1.79 | |||||
| FCF Yield % | -15.21 | |||||
| Forward Rate of Return (Yacktman) % | -3.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Il Yang Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 364,562.471 | ||
| EPS (TTM) (â‚©) | -43 | ||
| Beta | 0.72 | ||
| Volatility % | 21.26 | ||
| 14-Day RSI | 26.27 | ||
| 14-Day ATR (â‚©) | 266.531623 | ||
| 20-Day SMA (â‚©) | 11649 | ||
| 12-1 Month Momentum % | -14.21 | ||
| 52-Week Range (â‚©) | 10970 - 16250 | ||
| Shares Outstanding (Mil) | 18.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Il Yang Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Il Yang Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Il Yang Pharmaceutical Co Ltd Frequently Asked Questions
What is Il Yang Pharmaceutical Co Ltd(XKRX:007570)'s stock price today?
The current price of XKRX:007570 is â‚©11090.00. The 52 week high of XKRX:007570 is â‚©16250.00 and 52 week low is â‚©10970.00.
When is next earnings date of Il Yang Pharmaceutical Co Ltd(XKRX:007570)?
The next earnings date of Il Yang Pharmaceutical Co Ltd(XKRX:007570) is .
Does Il Yang Pharmaceutical Co Ltd(XKRX:007570) pay dividends? If so, how much?
The Dividend Yield %  of Il Yang Pharmaceutical Co Ltd(XKRX:007570) is 1.35% (As of Today), Highest Dividend Payout Ratio of Il Yang Pharmaceutical Co Ltd(XKRX:007570) was 0.43. The lowest was 0.14. And the median was 0.23. The  Forward Dividend Yield % of Il Yang Pharmaceutical Co Ltd(XKRX:007570) is 1.35%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers